Edition:
India

Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

10.39USD
17 Aug 2018
Change (% chg)

$-0.06 (-0.57%)
Prev Close
$10.45
Open
$10.41
Day's High
$10.53
Day's Low
$10.30
Volume
99,132
Avg. Vol
196,295
52-wk High
$15.15
52-wk Low
$7.68

Latest Key Developments (Source: Significant Developments)

Lexicon Pharmaceuticals reports Q3 loss per share $0.29
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Lexicon Pharmaceuticals Inc :Lexicon Pharmaceuticals reports third quarter 2017 financial results and provides a business update.Q3 loss per share $0.29.Q3 revenue $26.9 million versus I/B/E/S view $27.7 million.Q3 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

Lexicon Pharmaceuticals agrees to buy remaining obligations to Symphony Icon
Wednesday, 5 Oct 2016 

Lexicon Pharmaceuticals Inc: Lexicon Pharmaceuticals announces agreement to buy out remaining obligations to Symphony Icon . Buyout payment may be payable in cash or a combination of cash and up to 50% in lexicon common stock, at Lexicon's option . Lexicon will make a single payment to Symphony Icon of $21.013 million .Buyout to replace, eliminate remaining contingent payments of up to $29.550 million for which co was obligated.  Full Article

BRIEF-Lexicon Pharmaceuticals Reports Q1 Loss Per Share $0.40

* LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE